Up a level |
Merola, E; Pascher, A; Rinke, A; Bartsch, D K; Zerbi, A; Nappo, G; Carnaghi, C; Ciola, M; McNamara, M G; Zandee, W; Bertani, E; Marcucci, S; Modica, R; Grützmann, R; Fazio, N; de Herder, W; Valle, J W; Gress, T M; Delle Fave, G; de Pretis, G; ... (2022). ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence. Annals of surgical oncology, 29(9), pp. 5580-5581. Springer 10.1245/s10434-022-12049-3
Rindi, G; Falconi, M; Klersy, C; Albarello, L; Boninsegna, L; Buchler, M W; Capella, C; Caplin, M; Couvelard, A; Doglioni, C; Delle Fave, G; Fischer, L; Fusai, G; de Herder, W W; Jann, H; Komminoth, P; de Krijger, R R; La Rosa, S; Luong, T V; Pape, U; ... (2012). TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. Journal of the National Cancer Institute JNCI, 104(10), pp. 764-77. Cary, N.C.: Oxford University Press 10.1093/jnci/djs208
O'Toole, D; Grossmann, A; Gross, D; Delle Fave, G; Barkmanova, J; O'Connor, J; Pape, UF; Plöckinger, U; Mallorca-Consensus-Conference, Participants; European-Neuroendocrine-Tumor, Society (2009). ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology, 90(2), pp. 194-202. Basel: Karger 10.1159/000225948
Nilsson, O; Van Cutsem, E; Delle Fave, G; Yao, JC; Pavel, ME; McNicol, AM; Sevilla Garcia, MI; Knapp, WH; Kele, timur F; Sauvanet, A; Pauwels, S; Kwekkeboom, DJ; Caplin, M; Frascati, Consensus Conference; European, Neuroendocrine Tumor Society (2006). Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology, 84(3), pp. 212-5. Basel: Karger 10.1159/000098013
Ruszniewski, P; Delle Fave, G; Cadiot, G; Komminoth, P; Chung, D; Kos-Kudla, B; Kianmanesh, R; Hochhauser, D; Arnold, R; Ahlman, H; Pauwels, S; Kwekkeboom, DJ; Rindi, G; Frascati, Consensus Conference; European, neuroendocrine Tumor Society (2006). Well-differentiated gastric tumors/carcinomas. Neuroendocrinology, 84(3), pp. 158-64. Basel: Karger 10.1159/000098007